Your Status: Logged out Log in

Ovarian cancer  

Member rating: No Rating | Words: | Submitted: Fri Jan 28 2005

Page Preview
Preview
Previous 1 of 13 Next

On the left is an image preview of every page of this document, and below are the first 150 words with formatting removed:

╨╧рб▒с>■  oq■   n                                                                                                                                                                                                                                                                                                                                                                                                                                                ье┴5@ Ё┐0 Бbjbj╧2╧2 (кнXнXQwн      ИЪЪЪЪЪЪЪоооо8ц ЄМоПvКККККККК$RWК4ЪККККК4ЪЪККI▄▄▄КЪКЪК▄К▄▄юЪЪюК~ аМ└cаЛ╟оКю_0Пюс КRс юооЪЪЪЪс Ъю КК▄ККККК44▄ Of all gynecologic malignancies, ovarian cancer continues to have the highest mortality and is the most difficult to diagnose. In the United States female population, ovarian cancer ranks fifth in absolute mortality among cancer related deaths (13,000/yr). In most reported cases, ovarian cancer, when first diagnosed is in stages III or IV in about 60 to 70% of patients which further complicates treatment of the disease (Barber, 3). Early detection in ovarian cancer is hampered by the lack of appropriate tumor markers and clinically, most patients fail to develop significant symptoms until they reach advanced stage disease. The characteristics of ovarian cancer have been studied in primary tumors and in established ovarian tumor cell lines which provide a reproducible source of tumor material. Among the major clinical problems of ovarian cancer, malignant progression, rapid emergence of drug resistance, and...

To see the full version of this document, and 144,846 others

Register Now